Reproducibility of blood pressure response to hydrochlorothiazide
- PMID: 12461303
- PMCID: PMC8101852
- DOI: 10.1111/j.1524-6175.2002.00965.x
Reproducibility of blood pressure response to hydrochlorothiazide
Abstract
Few studies have investigated the reproducibility of responses to antihypertensive therapies. The purpose of this study was to assess the reproducibility of the blood pressure response to a thiazide diuretic, a preferred initial treatment for hypertension. Twenty-two subjects who underwent monotherapy with hydrochlorothiazide as part of a study to identify predictors of blood pressure response agreed to undergo the same protocol a second time, 26.6+/-11.8 (range, 4-52) months after their first participation. The mean systolic and diastolic blood pressure responses to hydrochlorothiazide did not differ significantly between the first and second participation (systolic response, -14.2+/-16.4 mm Hg vs. -16.0+/-16.5 mm Hg; diastolic response, -7.1+/-11.8 mm Hg vs. -6.6+/-8.6 mm Hg), and these responses were significantly correlated between the two trials (systolic response, r=0.61 and p<0.01; diastolic response, r=0.64 and p<0.01). However, both the direction and magnitude of responses for individual subjects varied considerably, with the limits of agreement between the first and second participations (i.e., 2 standard deviations above and below the mean difference between responses) ranging from 27.4 mm Hg to -23.8 mm Hg for systolic blood pressure response and from 17.4 mm Hg to -18.4 mm Hg for diastolic blood pressure response. These results show that the average systolic and diastolic blood pressure responses to hydrochlorothiazide for a group of subjects are reproducible; however, the responses for individual subjects are unpredictable.
Copyright 2002 Le Jacq Communications, Inc.
Similar articles
-
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.Arch Intern Med. 2001 Apr 9;161(7):965-71. doi: 10.1001/archinte.161.7.965. Arch Intern Med. 2001. PMID: 11295959 Clinical Trial.
-
Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.Am J Cardiol. 1999 Jul 1;84(1):70-5. doi: 10.1016/s0002-9149(99)00194-0. Am J Cardiol. 1999. PMID: 10404854 Clinical Trial.
-
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.
-
Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.Drugs. 2002;62(13):1983-2005. doi: 10.2165/00003495-200262130-00015. Drugs. 2002. PMID: 12215069 Review.
-
Treating essential hypertension. The first choice is usually a thiazide diuretic.Prescrire Int. 2014 Sep;23(152):215-20. Prescrire Int. 2014. PMID: 25325125 Review.
Cited by
-
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.J Transl Med. 2012 Mar 13;10:47. doi: 10.1186/1479-5876-10-47. J Transl Med. 2012. PMID: 22413836 Free PMC article. Clinical Trial.
-
Gene markers and antihypertensive therapy.Curr Hypertens Rep. 2005 Feb;7(1):21-30. doi: 10.1007/s11906-005-0051-y. Curr Hypertens Rep. 2005. PMID: 15683583 Review.
-
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.Hypertension. 2008 Aug;52(2):359-65. doi: 10.1161/HYPERTENSIONAHA.107.104273. Epub 2008 Jun 30. Hypertension. 2008. PMID: 18591461 Free PMC article.
-
Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.Expert Rev Precis Med Drug Dev. 2018;3(1):33-47. doi: 10.1080/23808993.2018.1420419. Epub 2018 Jan 3. Expert Rev Precis Med Drug Dev. 2018. PMID: 29888336 Free PMC article.
References
-
- Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997; 157( 21): 2413 – 2446. - PubMed
-
- Turner ST, Schwartz GL, Chapman AB, et al. C825T polymorphism of the G protein 3‐subunit and hypertensive response to a thiazide diuretic. Hypertension. 2001; 37: 739 – 743. - PubMed
-
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307 – 310. - PubMed
-
- Zoccali C, Mallamaci F, Cuzzola F, et al. Reproducibility of the response to short‐term low salt intake in essential hypertension. J Hypertens. 1996; 14: 1455 – 1459. - PubMed
-
- Chatellier G, Day M, Bobrie G, et al. Feasibility study of Nof‐ 1 trials with blood pressure self‐monitoring in hypertension. Hypertension. 1995; 25( 2): 294 – 301. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical